Stock Track | Moderna, Inc. Soars 5.09% in Pre-Market on Strong Q4 Guidance and Improved Financial Outlook

Stock Track

Yesterday

Moderna, Inc. (NASDAQ: MRNA) saw its stock surge 5.09% in pre-market trading on Friday, reflecting renewed investor confidence in the biotech company.

The rally follows Moderna's better-than-expected full-year 2025 outlook, with revenue now projected at $1.9 billion, $100 million above the midpoint provided earlier. The company also improved its cost picture, lowering its GAAP operating expense forecast by roughly $200 million and increasing its projected year-end cash balance to $8.1 billion. These positive financial updates have fueled significant optimism among investors.

Additionally, Moderna's Momentum score in Benzinga’s Edge Stock Rankings has surged from 22.5 to 74.61 in just one week, indicating a sharp turnaround in investor sentiment. The stock has gained 76% from its November 2025 lows, with shares climbing 31.7% in the past month and 14.8% over the past week alone.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1139582737"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1139582737\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1139582737?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-16 21:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139582737","market":"hk","top_or_hot":-1,"title":"Stock Track | Moderna, Inc. Soars 5.09% in Pre-Market on Strong Q4 Guidance and Improved Financial Outlook","media":"Stock Track","content":"<p>Moderna, Inc. (NASDAQ: MRNA) saw its stock surge 5.09% in pre-market trading on Friday, reflecting renewed investor confidence in the biotech company.</p><p>The rally follows Moderna's better-than-expected full-year 2025 outlook, with revenue now projected at $1.9 billion, $100 million above the midpoint provided earlier. The company also improved its cost picture, lowering its GAAP operating expense forecast by roughly $200 million and increasing its projected year-end cash balance to $8.1 billion. These positive financial updates have fueled significant optimism among investors.</p><p>Additionally, Moderna's Momentum score in Benzinga’s Edge Stock Rankings has surged from 22.5 to 74.61 in just one week, indicating a sharp turnaround in investor sentiment. The stock has gained 76% from its November 2025 lows, with shares climbing 31.7% in the past month and 14.8% over the past week alone.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna, Inc. Soars 5.09% in Pre-Market on Strong Q4 Guidance and Improved Financial Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna, Inc. Soars 5.09% in Pre-Market on Strong Q4 Guidance and Improved Financial Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-16 21:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (NASDAQ: MRNA) saw its stock surge 5.09% in pre-market trading on Friday, reflecting renewed investor confidence in the biotech company.</p><p>The rally follows Moderna's better-than-expected full-year 2025 outlook, with revenue now projected at $1.9 billion, $100 million above the midpoint provided earlier. The company also improved its cost picture, lowering its GAAP operating expense forecast by roughly $200 million and increasing its projected year-end cash balance to $8.1 billion. These positive financial updates have fueled significant optimism among investors.</p><p>Additionally, Moderna's Momentum score in Benzinga’s Edge Stock Rankings has surged from 22.5 to 74.61 in just one week, indicating a sharp turnaround in investor sentiment. The stock has gained 76% from its November 2025 lows, with shares climbing 31.7% in the past month and 14.8% over the past week alone.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1139582737","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139582737","pubTimestamp":1768570461,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc. (NASDAQ: MRNA) saw its stock surge 5.09% in pre-market trading on Friday, reflecting renewed investor confidence in the biotech company.The rally follows Moderna's better-than-expected...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"个股追踪|Moderna，Inc.盘前飙升5.09%，因强劲的Q4指引和改善的财务前景","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (NASDAQ: MRNA) saw its stock surge 5.09% in pre-market trading on Friday, reflecting renewed investor confidence in the biotech company.The rally follows Moderna's better-than-expected full-year 2025 outlook, with revenue now projected at $1.9 billion, $100 million above the midpoint provided earlier. The company also improved its cost picture, lowering its GAAP operating expense forecast by roughly $200 million and increasing its projected year-end cash balance to $8.1 billion. These positive financial updates have fueled significant optimism among investors.Additionally, Moderna's Momentum score in Benzinga’s Edge Stock Rankings has surged from 22.5 to 74.61 in just one week, indicating a sharp turnaround in investor sentiment. The stock has gained 76% from its November 2025 lows, with shares climbing 31.7% in the past month and 14.8% over the past week alone.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}